Henry J. Johnson

501 total citations
13 papers, 364 citations indexed

About

Henry J. Johnson is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Henry J. Johnson has authored 13 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Pharmacology. Recurrent topics in Henry J. Johnson's work include Hormonal and reproductive studies (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Prostate Cancer Treatment and Research (3 papers). Henry J. Johnson is often cited by papers focused on Hormonal and reproductive studies (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Prostate Cancer Treatment and Research (3 papers). Henry J. Johnson collaborates with scholars based in United States and United Kingdom. Henry J. Johnson's co-authors include Mark C. Scholz, Stephen B. Strum, J E McDermed, Glenn Tisman, Robert I. Jennrich, Richard Y. Lam, Ronald L. Baron, Stanley A. Brosman, Ray Redheffer and James L. Casterline and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neurochemistry and The Journal of Urology.

In The Last Decade

Henry J. Johnson

12 papers receiving 350 citations

Peers

Henry J. Johnson
Ju Young Yoon South Korea
Yuko Kita Japan
Lea R. Gordon United States
Sana Raza India
Henry J. Johnson
Citations per year, relative to Henry J. Johnson Henry J. Johnson (= 1×) peers Mei‐Hui Lee

Countries citing papers authored by Henry J. Johnson

Since Specialization
Citations

This map shows the geographic impact of Henry J. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry J. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry J. Johnson more than expected).

Fields of papers citing papers by Henry J. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry J. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry J. Johnson. The network helps show where Henry J. Johnson may publish in the future.

Co-authorship network of co-authors of Henry J. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Henry J. Johnson. A scholar is included among the top collaborators of Henry J. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry J. Johnson. Henry J. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
3.
Scholz, Mark C., et al.. (2006). Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period. The Journal of Urology. 175(5). 1673–1678. 24 indexed citations
4.
Scholz, Mark C., et al.. (2006). Ultrasensitive PSA nadir on testosterone inactivating pharmaceuticals accurately predicts early prostate cancer progression. Journal of Clinical Oncology. 24(18_suppl). 14531–14531. 1 indexed citations
5.
Scholz, Mark C., Robert I. Jennrich, Stephen B. Strum, et al.. (2005). LONG-TERM OUTCOME FOR MEN WITH ANDROGEN INDEPENDENT PROSTATE CANCER TREATED WITH KETOCONAZOLE AND HYDROCORTISONE. The Journal of Urology. 173(6). 1947–1952. 36 indexed citations
6.
Scholz, Mark C., et al.. (2003). Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study. Prostate Cancer and Prostatic Diseases. 6(4). 301–304. 72 indexed citations
7.
Jennrich, Robert I., et al.. (2002). Using splines to detect changes in PSA doubling times. The Prostate. 54(2). 88–94. 11 indexed citations
8.
Strum, Stephen B., J E McDermed, Mark C. Scholz, Henry J. Johnson, & Glenn Tisman. (1997). Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade. British Journal of Urology. 79(6). 933–941. 159 indexed citations
9.
Johnson, Henry J., et al.. (1978). Ketamine and Promazine for Anesthesia in the Rat. Journal of the American Veterinary Medical Association. 173(9). 1252–1253. 1 indexed citations
10.
Johnson, Henry J., et al.. (1966). CHOLESTEROL CONTENT OF SPINAL CORD AND SCIATIC NERVE OF HENS AFTER ORGANOPHOSPHATE AND CARBAMATE ADMINISTRATION. Journal of Neurochemistry. 13(6). 471–474. 5 indexed citations
11.
Johnson, Henry J., et al.. (1965). Effects of certain metabolically active drugs and oximes on tri-o-cresyl phosphate toxicity. Toxicology and Applied Pharmacology. 7(2). 227–235. 25 indexed citations
12.
Baron, Ronald L., et al.. (1965). Neurological Disruption Produced in Hens by Two Organophosphate Esters. Journal of Occupational and Environmental Medicine. 7(5). 241–241. 1 indexed citations
13.
Baron, Ronald L. & Henry J. Johnson. (1964). NEUROLOGICAL DISRUPTION PRODUCED IN HENS BY TWO ORGANOPHOSPHATE ESTERS. British Journal of Pharmacology and Chemotherapy. 23(2). 295–304. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026